Massachusetts-based Be Biopharma will use the proceeds to build a team as it seeks to develop B-cell therapies for a variety of diseases.
Improving patient safety and increasing the bottom line aren’t competing priorities. Here’s how hospitals can accomplish both objectives.
The app, developed by the Commons Project Foundation and the World Economic Forum, lets travelers share vaccination records, Covid-19 test results and health declarations.
Insurance startup Bind Benefits just raised $105 million in a Series B funding round to further expand into the fully insured market. CEO Tony Miller sees the company’s health plan product as a way for employers to stay agile while offering insurance in a rapidly… Read More »How Bind Benefits’ CEO will use $105M to upend the health insurance market
The Los Angeles-based startup received a breakthrough device designation from the FDA for using VR to manage chronic pain. It recently published the results of a 92-person virtual trial testing VR for pain management at home.
There is a surging demand for pre-sterilized surgical technologies at healthcare facilities because of the desire to both curb risk factors associated with Covid-19 at hospitals and also reduce the possibility of bacterial co-infections.
To keep critical revenue flowing, hospitals and ambulatory surgery centers need to resume elective surgeries and procedures as quickly as possible and mobile apps can help by giving patients and staff vital information, provide advance symptom screening and help providers reduce elective procedure no-shows through… Read More »Technology can ease pandemic challenges faced by hospitals, ambulatory surgery centers
Landmark FDA approval of antiviral drug as 1st COVID-19 treatment comes amid conflicting efficacy data
The Food and Drug Administration approved Gilead’s antiviral drug as the first treatment for Covid-19 but just last week a WHO report showed that the drug appeared to have little to no effect on hospitalized patients.
The company, which offers a remote scribe services, secured $25 million in private placement financing and began trading publicly on the OTC markets after a reverse merger with Malo Holdings.
By making responsible and strategic technology investments, practitioners will have access to robust data, be in a position to analyze and interpret trends and outcomes and provide health care informatics that ultimately will be the insights they need to be successful in a value-based health… Read More »Best practices for physicians in adopting compliant and efficient data sharing
The partnership will combine in-home caretakers with Doctor on Demand’s telehealth services. Some of CareLinx users will be able to access virtual visits for free.
Covid-19 has presented the possibility of reinventing healthcare delivery and reimbursement must support this
While there are encouraging signs of reimbursement falling in step with the move towards a more value-based healthcare system, what is needed now to further encourage healthcare innovators is to properly rationalize approval processes imposed by the FDA and CMS.
Nice Healthcare, a Minnesota-based startup that offers telemedicine and primary care services, raised $5 million in seed funding. The company plans to use the funds to bring its benefits to businesses in more states.
In addition to monetary damages and the guilty pleas, the government is seeking to transform the maker of OxyContin into a public benefit company that would fund efforts to curb opioid abuse and give away drugs to prevent overdose deaths.
Using digital engagement to solve pain points along the patient journey: How to deliver better outcomes for patients and brands [Sponsored]
Join us November 10th to learn how digital engagement can solve challenges for both patients and the brand and learn other benefits that will improve patient experience and address multiple barriers to medication adherence.
The regulatory clearance would allow AIdoc’s system to be used to detect incidental pulmonary embolism, meaning that it could flag unsuspected findings in CT scans.
The disruption to biopharma and medtech businesses caused by Covid-19, such as product launch and clinical trial delays, has underscored the need for a more digital focused strategy.
After Nebraskans cast their vote for Medicaid expansion in 2018, the state is finally expanding coverage to more residents. As part of the state’s rollout, it split its expanded Medicaid plans into two tiers, with work and other requirements to access dental and vision coverage.
When discussing the role of AI in Covid-19, we have to reframe this conversation and look at AI as an important approach that can provide better analysis and ultimately better outcomes for patients, not as replacing the entirety of the drug discovery process or as… Read More »Will Covid-19 be the straw that breaks AI’s back?
As hospital admissions rebound to near-normal levels, total admissions are still expected to be down 10.5% for the year, according to an analysis by the Epic Health Research Network and the Kaiser Family Foundation.
The deal with Roche subsidiary Genentech is likely not the last for Genesis Therapeutics, which is based on AI research undertaken at Stanford. Such partnerships are potentially lucrative for drug-discovery startups.
Starting in January, Medicare will pay $75 for tests that take longer than two days, and will only pay $100 per test to laboratories that process most of their Covid-19 tests in less than two days.
Radically improving health outcomes for vulnerable populations requires a multifaceted proactive, community-wide approach focused on better understanding social determinants of health and simultaneously addressing social and health inequalities.
The health IT company filed a lawsuit against telemedicine startup CarePortMD as it looks to sell its similarly named post-acute care subsidiary.
For the second year, MedCity News is partnering with the New Orleans Business Alliance to host an executive summit that focuses on population health and highlights where innovation and investment are occurring in the field.
With so many incredible advancements in technology in the healthcare space, it’s important to understand where exactly these developments have a measurable impact.
Global healthcare funding set a new record in the third quarter, according to data from CBInsights. Healthcare companies raised a total of $21.8 billion across 1,539 deals.
Critics have faulted some technologies for potentially reinforcing racial inequality. But a Deloitte exec painted a more optimistic picture at the HLTH conference.
The Bay Area hearing device-maker planned to raise $141.3 million in an upsized IPO. Its stock started trading on Nasdaq under the ticker “EAR.”
Imagine a world where every patient has access to a care manager armed with comprehensive, real-time data and the tools to take action.
With a new nominee as the Supreme Court prepares to hear a case that could determine the future of the Affordable Care Act, the health law’s future has been thrown into question. According to the Robert Wood Johnson Foundation, the number of uninsured could increase… Read More »Report: 21M people could lose insurance if ACA is overturned
The startup, which has seen its user base more than triple in the last year, plans to use the funds to further build out its platform.
Google’s sister company launched a program in California and other states to help route patients to nearby coronavirus testing. Dr. Vivian Lee, president of health platforms for Verily, shared lessons learned from that effort and Verily’s work with schools and businesses.
HLTH aimed to reflect on the success of the decade-old Center for Medicare and Medicaid Innovation (CMMI) by a panel discussion with its directors. Except the first director was never included while his successor tried claiming the mantle of the “inaugural director” riling former colleagues… Read More »A “bald-faced lie” on LinkedIn followed by revisionist history of CMMI at HLTH panel
San Diego-based diagnostics startup Cue Health won a $481 million from the Department of Health and Human Services and the Department of Defense to produce more coronavirus tests. The company received an emergency use authorization in June for its rapid molecular test.
Among the areas of interest for employee benefits startups that presented in our Pitch Perfect contest are: electronic patient care records, behavioral health, caregiver support and substance abuse treatment.
In a HLTH session Tuesday, an executive at the pharma company offered an update on its efforts to become a digital and data powerhouse.
Medicare doesn’t currently cover drugs approved under emergency use designations. But CMS Administrator Seema Verma said the agency was coming up with a plan to make sure Medicare beneficiaries were covered once a coronavirus vaccine is developed.
The companies made their first cross-sale to Guidewell Health, the parent company of Florida Blue. Livongo’s diabetes platform will become available to 50,000 of the insurer’s members.
This Pitch Perfect contest track includes home health startups with technologies spanning respiratory care, virtual nursing, and more.
The assurances come amid concerns that the Trump administration would brush aside scientific expertise in its push for a vaccine ahead of the election on Nov. 3.
By enabling a more hybrid approach to clinical trials with the added flexibility of telehealth, studies can improve patient-centricity, which will ultimately improve recruitment, engagement, and retention.
Patient engagement and experience were coming into focus as part of the overall transformation of healthcare, but the advent of Covid-19 has thrust it to the forefront. Hear from patients, providers, retailers, tech disruptors and others about why patient engagement is paramount.
The Silicon Valley startup plans to start its registration-directed study of Limbix Spark in the earlier part of next year and – if successful – would anticipate FDA clearance in early 2022.
The Palo Alto-based startup provides tools to support family caregivers, and uses predictive analytics to help them develop personalized action plans.
When it announced plans to go public through a blank-check company, Clover Health shared ambitious projections for its future membership. Much of that growth is pinned on plans to launch a direct contracting business.
Check out news from ChromaCode, Current Health, Datavant, and more.
The question isn’t if telemedicine has a future, but rather how ubiquitous it will be in our healthcare system moving forward.
The company has received FDA approvals for two cancer drugs in less than 12 months and announced partnerships with Merck last month for a Phase II antibody-drug conjugate and a marketed drug.
Startups with tech to improve payer and provider efficiency: Video from MedCity INVEST Digital Health
This Pitch Perfect contest track reflected technology to remove financial barriers for their patients, automating workflows, reducing inefficiency and waste associated with the Prior Authorization process, and more.
Healthcare providers won’t have to start paying back Medicare advance loans until a year after they were issued. Under the original timeline, hospitals were supposed to start paying back the loans in August.
Rideshare startup Lyft will integrate its concierge rides services with Epic’s electronic medical record system. The service allows healthcare providers and other businesses to order rides for their patients.
The companies will partner on development and commercialization of ARO-AAT, Arrowhead’s Phase II RNA-interference drug for alpha-1 antitrypsin-associated liver disease, a rare genetic disorder. An analyst wrote that the deal makes sense given Takeda’s position in the AAT-augmentation therapy market.
The prize went to Jennifer Doudna of the University of California Berkeley and Emmanuelle Charpentier of the Max Planck Institute. Charpentier published her research on the biology behind the technology in 2011 and collaborated with Doudna. The two discovered it was possible to control the… Read More »CRISPR gene-editing discoverers awarded Nobel Prize in chemistry
It’s important to leverage patient engagement tools to get in front of patients early in the season, reminding them to get their flu shot and educating them on the potential symptoms of both the seasonal flu and Covid-19
Starship, a startup making Health Savings Accounts easier to use, has seen an influx of users since the start of the pandemic. In the first six months of 2020, the company saw 500% growth in active accounts and plans to double its membership again by… Read More »Starship brings gig economy focus to health savings accounts
Health systems should embrace an omni-channel strategy that includes asynchronous virtual visit capabilities to better meet consumer needs, improve provider capacity, and enable more robust virtual care models.
The FDA granted an emergency use authorization to an algorithm developed by Dascena to predict which Covid-19 patients might face unstable blood pressure or respiratory decline.
The company announced data on the combination of two antibodies against the SARS-CoV-2 virus, showing significant reductions in viral load compared with placebo. The company has applied for an EUA for LY-CoV555 and will seek an authorization for the combination of that drug with LY-CoV016… Read More »Lilly seeks emergency clearance for Covid-19 monoclonal antibodies on Phase II data
Cancer Insights co-founders, President and CEO Tarun Kumar and CIO Dr. Sharon Hensley Alford, discuss their company’s goals to transform the oncology care continuum.
The guidance calls for a median two months’ worth of follow-up safety data from well-designed Phase III studies as a precondition for a vaccine receiving an EUA. The Wall Street Journal reported that the White House had backed down in its opposition to the guidance,… Read More »FDA issues Covid-19 vaccine guidance as White House reportedly relents
Startups focused on chronic conditions and value-based care: Video from MedCity INVEST Digital Health
Finalists in the Pitch Perfect contest track, chronic disease management and value-based care, span virtual care for patients with neurological disorders and family caregivers, digital therapeutics for adolescent mental health, and personalized nutrition coaching to address chronic disease risk.
Medicare Advantage startup Clover Health will go public in a blank-check acquisition led by billionaire Chamath Palihapitiya. The deal will value Clover at $3.7 billion.
AireHealth, which makes portable nebulizers for patients with respiratory conditions, plans to launch its first connected product next year.
While payers and policymakers took a more narrow-minded perspective on innovation value in 2020, the year 2021 will bring an increased focus on a treatment’s societal value, how innovation interacts with digital technologies, and whether new innovations are able to reduce existing health outcome inequalities.
The company did not provide data, but said results for patients who received sotorasib at the 960mg dose were consistent with those seen in the Phase I portion of the Phase I/II study, which showed an overall response rate of 35.3%. ……
Join us October 27th and hear the best practices and new perspectives to help re-engage with your customers during the coronavirus pandemic.
Members of the House and Senate have seen the need to boost the national stockpile with PPE that is made in America. Failure to do so would only exacerbate the problems when our healthcare system is stretched thin.
The companies expect the deal to close in the fourth quarter. MyoKardia’s lead drug candidate is mavacamten, which it is developing for hypertrophic cardiomyopathy and plans to submit to the FDA in the first quarter of next year.
HHS will renew its contract with TeleTracking Technologies for another $10.2 million. Earlier this year, HHS controversially shifted Covid-19 data collection to the company from the Centers for Disease Control and Prevention, which would normally handle data collection.
The investigation resulted in charges against more than 345 defendants for more than $6 billion in alleged fraud losses. Roughly $4.5 billion of that was connected to telemedicine, the Department of Justice said.
The findings may make it possible to identify a subset of patients who experience poorer outcomes or more serious side effects, especially neurotoxicity.
Trained clinical judgment and human compassion will always be irreplaceable, but robotics and automation can also provide predictable and repeatable movements, facilitating better standardization of treatment, which allows physicians to focus on clinical decision making.
While the White House and doctors at Walter Reed have sought to reassure the public that Trump’s condition is improving, he has received numerous drugs for Covid-19, including the steroid dexamethasone, which is typically administered only to those who are critically ill.
Addressing behavioral health challenges for patients and employees: Video from MedCity INVEST Digital Health
In the latest video installment from INVEST Digital Health Virtual, a panel looks at behavioral health from the loneliness epidemic, workplace stress, and other challenges and the innovative tools developed to address these needs.
Chance Scott, a Director in life sciences at Guidehouse, talks about some of the challenges digital health innovators face, from reimbursement by private plans to the future of reimbursement for other telehealth tools and digital therapeutics.
Consumer healthcare behavior is changing: 3 changes that will stick post-Covid in the healthcare revenue cycle
What are the Covid-related changes in consumer behavior that will stick in the healthcare revenue cycle following the pandemic? Here are three trends that could reshape customer service in the revenue cycle.
The company said it was meeting real-time supply demands for Veklury (remdesivir) in the U.S. and anticipated meeting global demands for the drug worldwide. AmerisourceBergen will continue acting as sole U.S. distributor.
The insurer plans to increase the footprint for its Medicare Advantage plans by 50%, adding plans in 300 additional counties.
Remote IT teams are now a viable solution for startups and established firms to tap into the global pool of software engineers to meet their need to expand development teams rapidly. But how do you successfully vet, onboard, and manage remote software developers?
The plans will include zero-dollar premiums and will give patients access to free primary care visits, dental exams and lab tests at Walmart Health centers across the state.
Read about new developments from healthcare startups such as Carrum Health, Siren, NeuroFlow, and more.
It’s crucial that today’s providers, innovators, and regulators alike continue to push for such tech adoption, driving virtual, continuous care in populations disproportionately affected by disease.
The company, which was a winner of the MedCity INVEST Digital Health Pitch Perfect contest, was founded with the aim of using digital technology to improve the experience and efficiency of prior authorizations, in particular determining whether they are needed.
In the latest video installment from INVEST Digital Health, venture capitalist Michael Yang, Managing Partner, OMERS Ventures, and healthcare entrepreneur Shawn Wagoner, Chief Revenue Officer, Bind Benefits, go head to head to debate the future of health insurance.
Amwell expanded its partnership with Tyto Care, a startup that makes connected exam kits for telehealth visits. The companies will design new integrations of their technologies, and Amwell will become a reseller of Tyto Care’s devices.
The direct-to-consumer telehealth startup will go public through a merger with special purpose acquisition company Oaktree Acquisition Corp. The combined entity is expected to be valued at $1.6 billion.
The data from a Phase II pilot and an extension study of soticlestat, also known as OV935 or TAK-935, showed short- and long-term reductions of seizure frequency in patients with CDKL5 deficiency disorder and Dup15q syndrome.
Reuters reported Wednesday that U.S. regulators would look at data from previous clinical trials that came from the same scientists who created the vaccine, AZD1222, which originated at the University of Oxford and is also known as ChAdOx1 nCoV-19.
Although the deadline for compliance with the FHIR patient access rules is fast approaching, most payers are not prepared,
We’re making video segments from our INVEST Digital Health conference available for viewing. The first of these installments is a panel discussion on innovation in hospital settings during the public health crisis.
A malware attack brought hospital chain Universal Health Services’ IT systems down at the beginning of the week. Cybersecurity experts said hospitals should expect more of these attacks, as recovery can be costly.
Moderna’s Covid-19 vaccine shows antibody, T-cell responses a month after second dose in interim Phase I data
The company published interim data from the Phase I study of mRNA-1273 in 40 older and elderly adults, showing responses comparable to those seen in younger adults. The vaccine is being tested in a 30,000-participant Phase III trial.
Anthem will pay $39.5 million in a settlement related to a cyberattack in 2015. The settlement, reached with a group of state attorneys general, is separate from a class action case over the breach that Anthem settled in 2018.
It is unclear why the American Cancer Society would potentially impact the lives of countless women with recommendations that contradict decades of real progress.
While providers diagnose and treat in the hospital, care coordinators go beyond the four walls of that facility, into the community, and meet patients where they are, both literally and figuratively.
The company said that those who received the two-antibody cocktail REGN-COV2 showed a lower viral loads and faster alleviation of symptoms than those who received placebo.
The Office of the National Coordinator for Health Information Technology will update data measuring physician use of health IT systems, as well as physician burden and interoperability.
Molina announced it will acquire the assets of Affinity Health Plan, a New York-based Medicaid managed care organization. It’s one of several Medicaid MCO purchases the insurer has announced this year.
How the intelligence-based health system will become critical to meet patient needs today and post-Covid-19
To enable greater health access, the healthcare industry must modernize. We need systems rooted in intelligence for a healthier tomorrow.
The six-year-old Google-backed company was founded by three MIT physicists and hopes to use its technology to make drug discovery faster and less cumbersome by combining physics, AI and cloud computing.
A review published in JAMA found that bills introduced into the House and Senate don’t go nearly as far as existing drug pricing regulations other countries. The researchers listed eight key lessons from six nations.
Plume provides access to telehealth consultations for patients seeking gender-affirming hormone therapy. Recently, the startup began partnering with employers to offer its services as a benefit.
In rearchitecting the system by training every care provider in every specialty, and enable lower-cost providers and communities, we will provide a new model of care where a physician isn’t the person who helps us when we’re sick — they help us be healthy.
The INVEST Digital Health Virtual conference Pitch Perfect competition, from September 21-25, had some intense competition between the healthcare startup participants. Thanks to all the entrepreneurs, judges and sponsors who took part.
Premera will pay nearly $7 million in a settlement related to a security breach in 2014 affecting more than 10 million people. It will be the second-largest HIPAA fine to date.
The company hopes to use the money to bring its T-cell antigen coupler cell therapy technology – currently in preclinical development – into human clinical trials. German drugmaker Bayer’s venture capital arm led the round.
The whistleblower case alleged that an electronic health records company acquired by Konica Minolta cheated on certification tests to hide software issues.
We’re beating Covid-19 by sharing resources. Why stop there? By pooling select healthcare resources, we could also collectively buy supplies in bulk, lowering costs for everyone and minimizing our exposure to supply chain disruptions after the pandemic.
GoodRx, a digital health startup that helps users track prescription drug prices, filed for an IPO on Friday. The company hasn’t yet priced its shares, but plans to be listed on Nasdaq as “GDRX.”
The two companies had been negotiating a six-year value-based contract prior to the start of the pandemic. Allina and BCBS of Minnesota expect the agreement will affect roughly 130,000 patients.
To achieve the technological agility required to function in the modern world, healthcare organizations are wise to pursue managed services and utilize the power of cloud service providers.
The company announced Wednesday the FDA approval of its liquid biopsy test, the second to win an agency nod in less than a month, saying it would launch the product on Friday. The FDA acquired the first ever liquid biopsy companion diagnostic, Guardant Health’s Guardant360… Read More »Foundation Medicine to launch liquid biopsy companion diagnostic following FDA approval
How do we improve behavioral health in meaningful ways? Join the conversation at INVEST Digital Health.
A panel discussion at the conference will examine what is being done to address behavioral health needs from social isolation, accentuated by the public health crisis, to the stress experienced by healthcare professionals.
The e-commerce giant made its debut in the wearables market with Halo, a fitness tracker with some unique features. Amazon said the device and its corresponding app can scan a user’s voice for emotions and measures a user’s body composition.
New rules by the Center for Medicare and Medicaid Services would penalize hospitals and laboratories that report Covid-19 data. Hospitals would be required to report the number of confirmed or suspected Covid-19 patient, occupied beds, and availability of ventilators and other critical supplies.
There will always be a place for face-to-face care, but the shift to virtual care will drive a more intentional and cost-effective use of such in-person interaction.
Generic drugmaker Teva indicted in alleged price-fixing conspiracy leading consumers to be overcharged by $350M
The charges, filed in Philadelphia federal court, allege that Teva conspired with four other generic drug companies to fix prices, rig bids and allocate customers. Teva – which the Justice Department and New York’s state government also sued this month for unrelated allegations – said… Read More »Generic drugmaker Teva indicted in alleged price-fixing conspiracy leading consumers to be overcharged by $350M
The drug, AZD7442, is designed to potentially provide at least six months of protection from Covid-19. The trial, which is funded by federal defense and health authorities in the U.S., is enrolling up to 48 healthy volunteers in the U.K. AstraZeneca’s double-antibody approach is similar… Read More »AstraZeneca starts Phase I study of long-acting double-antibody cocktail for Covid-19
A report by Kaufman Hall showed that while hospitals’ operating margins improved in July, they were down 96% since the start of the year. Including funding allocated through the CARES Act. Without CARES Act funding, hospital margins were still down 28%.
Fitbit’s new, $330 smartwatch has a slew of new features, including a wrist-based temperature sensor and a sensor to monitor stress.
Dynamic personnel shifts, technology embrace, and significant behavior change will allow for rapid evolution of the healthcare industry and create the opportunity for alliances across the care continuum.
A survey of consumers with health insurance spells out how they want payers to communicate with them and how frequently. It also touches on the impact of Covid-19 on care delivery.
Study uses genomic data to trace Covid-19 ‘superspreader’ event linked to February Biogen exec meeting
The study, by researchers at Harvard, MIT, The Broad and other institutions, used genomic analysis of cases linked to the Biogen meeting, linking much of the community transmission in the Boston area to a European genetic variant of SARS-CoV-2 that first appeared at the meeting.
The healthcare analytics company said it had raised the extension funding from three new investors and would use it to accelerate development of its real-world evidence technology.
Mental health startup Lyra Health raised a $110 million series D, valuing the company at $1.1 billion. The company plans to use the funds to expand its teletherapy service and develop additional mental health solutions.
Alphabet’s healthcare subsidiary, Verily, will partner with Swiss Re Corporate Solutions to create a new stop-loss insurance company. The new entity, called Coefficient, will use data analytics to help self-funded companies manage unexpected areas of cost.
In an interview, Peter Meath, J.P. Morgan’s co-head of Healthcare and Life Sciences, Middle Market Banking & Specialized Industries, says the Covid-19 pandemic has cast a bright light on the life sciences industry with startups raising venture funding at record levels as the virus has… Read More »J.P. Morgan on the state of life sciences and strategies to fuel innovation [Sponsored]
The FDA commissioner took to Twitter Monday night to defend his performance at the agency, which came under sharp criticism amid accusations that the authorization of a plasma treatment for Covid-19 was politically motivated and that he stood by while President Trump unfairly maligned FDA… Read More »Stephen Hahn and the terrible, horrible, no good, very bad FDA weekend
The biotech company reached a deal with the European Commission to supply an initial 80 million doses, while European Union member states will have the option to purchase 80 million more.
Price transparency is no longer a nice to have, it’s a must-have as consumers’ wallets increasingly run dry.
Amwell filed preliminary paperwork for an IPO. The telehealth company also struck a partnership with Google, which will buy $100 million of its class C common stock.
While the emergency use authorization granted Sunday was not seen as scientifically unwarranted, it drew concerns from some experts that it could hinder enrollment in clinical trials, while the timing and circumstances of the FDA’s move fueled suspicions that political pressure – rather than science… Read More »FDA’s emergency authorization for convalescent plasma in Covid-19 sparks controversy
Outset Medical, a San Jose-based company making portable dialysis machines, filed the initial paperwork for an IPO. The company has not yet set a price range for its stock, but said it plans to raise roughly $100 million.
Kronos Bio raises $155M in private financing to advance lead leukemia drug into registration study next year
The company has raised $148 million so far and plans to raise the remaining $7 million by next month. Its lead candidate is entospletinib, a SYK inhibitor acquired as part of a deal with Gilead Sciences last month, under development for patients with biomarker-defined acute… Read More »Kronos Bio raises $155M in private financing to advance lead leukemia drug into registration study next year
Though the rest of 2020 is still unknown, one fact is very clear: Clinicians will need to continue to lean heavily on technology like RPM, AI and telehealth to ensure successful patient outcomes across the board.
Trump launches baseless attack on FDA; agency controversially authorizes plasma treatment for Covid-19
Over the weekend, Trump called the agency, without evidence, part of a “deep state” that was slow-walking vaccines and drugs for Covid-19. The next day, the agency authorized convalescent plasma despite having turned it down shortly before due to insufficient evidence.
The upcoming INVEST Digital Health virtual conference September 21-25 will offer a spotlight for this debate to continue. It will also include conversations spanning behavioral health and how hospitals are addressing the pandemic as well as healthcare startup pitches.
Fully-credentialled e-doctors still don’t exist, at least not in their entirety but major elements of the concept have already been deployed in the field, and progress toward a more comprehensive e-doc is well underway.
The companies also said their Phase II/III study, slated to enroll about 30,000 participants, had already dosed more than 11,000.
In a survey of 730 parents, 31% of them plan to keep their child home if schools open for in-person instruction, according to a survey published in JAMA Pediatrics. Many schools are still developing plans for remote and in-person instruction.
As RPA’s value for revenue cycle continues to be explored, leaders need to go beyond the hype and determine a practical path to innovation that takes into account the organization’s capacity for innovation and the road map that will best take the organization to its… Read More »Robotic Process Automation: The future of healthcare revenue cycle management
Even relatively healthy older adults see the benefit of receiving home-based primary care, not just because of its convenience, but because patients feel safer at home now, and more unsafe than ever in ambulatory settings surrounded by other sick patients.
After four Riverside Community Hospital employees contracted Covid-19, they and their families sued HCA for failing to provide adequate protections. The plaintiffs said they were not given adequate access to PPE, not warned when they might have been exposed to Covid-19, and were encouraged to… Read More »Lawsuit accuses HCA of failing to protect healthcare workers during pandemic
Read about news from healthcare startups Bright.MD, Science 37, NexEos Bio and more.
Once people recognized that the situation would be more than just a transient window, a growing number of healthcare and life sciences organizations took steps to deploy consistent and secure solutions to digitize a wide range of traditionally paper processes.
The clinical trial had already been placed on hold in connection with the two prior patient deaths, which were linked to the higher dose of 300 trillion viral vectors per kilogram, while no deaths have been reported among those receiving the lower dose of 100… Read More »Astellas’ Audentes Therapeutics discloses third patient death in gene therapy trial
The conference, in partnership with healthcare industry association Medical Alley, will include conversations spanning behavioral health, the future of health insurance and how hospitals are addressing the pandemic. It will also spotlight healthcare startups in a pitch contest.
Through a partnership with prescription delivery startup NimbleRx, Uber is offering home prescription delivery in Seattle and Dallas. The two companies plan to expand the partnership to other locations in the future.
A bankruptcy court in Delaware approved a stalking-horse bid from Otsuka to acquire Proteus Digital Health for $15 million. The company, which makes sensor that can be embedded in pills to track medication adherence, filed for bankruptcy in June.
Attaining reimbursement often has the greatest impact on patient access and can progress a new treatment toward widespread adoption.
The rise of digital in the health care ecosystem is also making the consumer experience increasingly fragmented and overly complex.
The New York Times reported that the FDA was prepared to issue an emergency use authorization for the treatment last week, but NIH Director Francis Collins and NIAID Director Anthony Fauci intervened, arguing that data were too weak.
The drugmaker emphasized the full global rights it would acquire to Momenta’s lead asset, nipocalimab, which it is developing for several autoantibody-driven diseases and that in certain indications could have peak sales of more than $1 billion.
INVEST Pitch Perfect winner spotlight: Sense Neuro Diagnostics wants to make stroke monitoring effective
Sense Neuro Diagnostics won the medical devices track of MedCity’s INVEST pitch contest and in an interview after that, the company’s CEO explains how he intends to make stroke monitoring of patients both efficient and cost-effective.
Some healthcare startups that offer at-home prescription deliveries and test kits have experienced delays with the USPS. They shared how they’re navigating the changes.
The Cleveland Clinic struck a partnership with CVS Health subsidiary Aetna to form a new accountable care organization (ACO). The two companies plan to launch a co-branded insurance plan this fall.
When employers offer a health plan with clear pricing, their employees are more likely to consistently choose higher-value, lower-cost care, according to a new Bind analysis using industry-leading national commercial benchmark and risk adjusted data. Register here to hear more.
In a CRL issued for valoctocogene roxaparvovec, the FDA told BioMarin that differences between its Phase I/II and Phase III studies limited the ability to rely on the earlier trial to support durability of effect, which an analyst said likely referred to a product comparability… Read More »FDA rejects BioMarin’s hemophilia A gene therapy in ‘massive surprise’
While there had been some risks to filgotinib’s approval cited before, analysts expressed surprise at the decision, with one writing it would likely delay approval by at least a year. Shares of both companies fell sharply on the news.
The deal brings Roche’s considerable manufacturing heft to Regeneron’s efforts to develop the two-antibody cocktail, REGN-COV2. Regeneron will distribute the drug in the U.S., while Roche will distribute it ex-U.S.
Providence posted a $221 million operating loss in the first half of 2020 due to the Covid-19 pandemic. The Washington-based health system saw patient volumes decline by 13% in the first six months.
Carrot Fertility, a startup that provides employee fertility benefits, raised $24 million in a series B round. The company plans to use the funds to further its expansion and build out its telehealth features.
The update to the partnership includes opt-in rights for Gilead on 15 drug targets, up from five under the original 2018 deal. Gilead will pay $125 million upfront and make a $20 million equity investment in Tango, which focuses on synthetic lethality.
Nearly all of the states, plus five territories and the District of Columbia, are seeking an aggregate of $2.156 trillion from the maker of the opioid painkiller OxyContin, according to documents filed in the U.S. Bankruptcy Court Monday.
Pleiogenix is a biopharma startup developing treatments for liver diseases as well as Covid-19 and non-alcoholic steatohepatitis (NASH). It recently emerged as the winner of the INVEST Pitch Perfect contest for the biopharma track.
A U.S. district judge blocked a rule by the Department of Health and Human Services that would end anti-discrimination provisions protecting transgender patients. In his decision, U.S. District Judge Frederic Block said that the rule violated a recent Supreme Court decision protecting LGBTQ workers’ rights.
The Centers for Medicare and Medicaid Services issued fines to more than 3,400 nursing homes either for infection control noncompliance or for failing to report Covid-19 data.
The agency approved Enspryng for the disease, which is often misdiagnosed as multiple sclerosis and can cause blindness, muscle weakness and paralysis.
Innovation in digital health at hospitals, in the face of Covid-19, and across digital health startups will be the highlights of the conference coming up September 21-25. Register now to get a $100 discount using the code MCN100.
The French drugmaker will take full control of SAR442168, a BTK inhibitor developed for multiple sclerosis that it in-licensed from the California biotech company in 2017.
Every lawyer knows that, in a courtroom, one should never ask a question one does not know the answer to. The same holds true for a CEO holding a board meeting. Preparation, such as holding one-on-one meetings with board members ahead of the event, is… Read More »Best practices for running a board meeting: What healthcare entrepreneurs need to know
Earlier this month, Ohio Gov. Mike DeWine received a false-positive result from a rapid antigen test for Covid-19, raising concerns about the tests’ accuracy. The assay’s maker, Quidel, said it is investigating the case.
During the height of the Covid-19 pandemic, all of the seven largest commercial insurers saw their profits rise, with some seeing their profits double. Will they have to pay some of it back?
Thirty Madison, which owns direct-to-consumer pharmacy brands for hair loss, migraines and acid reflux, raised $47 million in a series B round. Polaris Partners led the round, and Johnson & Johnson participated as an investor.
As virtual care is only going to grow in the coming months as a solution to pent-up demand for care that has resulted from the pandemic, focused attention is needed to address these operational and reimbursement issues.
If you just need blood drawn, do you really need to go to a hospital or your local lab? Wouldn’t it be easier on you (and less costly to everyone) if you could just prick your finger at your kitchen table and send in your… Read More »The evolution of healthcare and technology in the ‘hospital of tomorrow’
The company plans to train 250 new racially and ethnically diverse clinical trial investigators and extend the reach of its trials to underserved rural and urban communities.
We need to keep in mind three key elements to successfully implement the final interoperability rules from CMS that require private payers to provide longitudinal claims data to members as well as the use of open APIs so a range of third-party applications can be… Read More »How payers and providers can address the CMS interoperability mandate
Check out news from healthcare startups including Bind, Reify Health, Bodyport and more.
Walmart caught the healthcare industry’s attention when it began opening primary care centers across Georgia, Florida and Illinois. But without its leader, will the effort still be able to keep its momentum?
The Chicago-based startup company plans to use the funding to further growth of its product offering and integration with EHRs and genetic testing partners.
HHS’ Office of the National Coordinator will allocate $2.5 million in CARES Act funding to health information exchanges to support public health uses of information from health information exchanges (HIEs). Five recipients will each get $500,000.
UnitedHealthcare sent a notice to plan members stating that it would no longer cover Descovy to prevent HIV, while Truvada – after it goes generic next month – will be covered for free. Gilead reported that Descovy for PrEP had offset a second-quarter fall in… Read More »Gilead got a boost from a newly approved PrEP drug. Now, a major insurer is dropping coverage
The MedCity INVEST Digital Health Virtual event, Sep 21-25 will spotlight healthcare startups in four categories. The application deadline is coming up quick: Friday, August 21 at 5pm ET! Read more to find out how to apply.
Lumeon, a startup building a platform to make virtual care delivery more reliable, raised $30 million. Optum Ventures and Endeavour Vision led the funding round.
In a commentary, physicians and pharmacists wrote that percentages of Black, Latino and Native American patients in two Phase III studies of the drug that the company is using for FDA approval were disproportionate to Covid-19’s incidence in those communities.
Flare Capital Partner Dan Gebremedhin explains what led the venture capital firm to invest in New York-based Eden Health and lead its recent Series B round.
The company’s software system is designed to streamline the work done by staff at clinical trial sites, such as manually copying information about patient recruitment and enrollment.
The agreement, which includes 100 million doses of mRNA-1273 and an option to acquire 400 million more, brings the total amount of money the biotech company has received from the federal government for its vaccine efforts to nearly $2.5 billion.
KaNDy’s lead product candidate, NT-814, is a non-hormonal treatment for symptoms of menopause. The drug completed Phase IIb testing and is slated to start Phase III testing next year.
Bodyport, a startup developing a scale intended to detect early signs of cardiovascular disease, raised $11.2 million in series A funding. The San Francisco-based company also struck a partnership with Brigham and Women’s Hospital.
Match without a flame: Why interoperability mandates still require operational, use-case specific platforms
Whether it’s solving a gap in care problem, or a payer/doctor connectivity problem there will always be individual use cases where multisided platforms (or health information exchanges) can and should connect to solve for information exchange at scale.
The potential that wearables have for helping detect early signs of Covid-19 and other infectious diseases, as well as monitoring patients, will make this technology a popular choice for healthcare organizations and consumers for the foreseeable future.
Russian President Vladimir Putin said a vaccine developed at a Moscow research institute that appears to still be in Phase I development among fewer than 100 participants had undergone all necessary tests.
Xealth, a company whose platform makes it easy to prescribe digital health tools and integrate them with patients’ health records, struck a partnership with Cerner. Both Cerner and LRVHealth invested $6 million into the startup.
For the quarter ending on June 30, when many health systems face a rising number of Covid-19 cases, the Kaiser Foundation Health Plan more than doubled its net income to $4.5 billion. The nonprofit managed care plans attributed the increase to reduced operating expenses and… Read More »Kaiser sees Q2 net income more than double to $4.5B
The conference coming up September 21-25 will highlight innovation in digital health at hospitals, in the face of Covid-19, and across digital health startups. Register now to get a $100 discount using the code MCN100.
Analysts noted that Evrysdi would be priced significantly lower than Biogen’s Spinraza or Novartis’ Zolgensma. While this will provide a market advantage, it would also yield lower per-patient revenues.
In a phone interview, Guardant Health CEO Helmy Eltoukhy said he expected the approval to encourage coverage by those payers still on the sidelines.
Addressing Covid-19 is a data problem – here’s how the data community is harnessing healthcare data to solve it
Data can allow us to improve our public health response to the pandemic, but only if we enable data scientists with the right tools to harness those datasets.
News from innovative healthcare startups from Specifica, Aerovate Therapeutics and more.
MedCity News has the most engaged healthcare business audience in the industry. We can collaborate with you to develop customized content or provide a platform for your business to present sponsored thought leadership content highlighting from executives in healthcare and life sciences.
The disproportionate impact of the pandemic on the underserved, Black Americans, Latinos, and those with chronic conditions requires an industry-wide foundational response.
Gilead Sciences had said in its second-quarter earnings that it would partner with companies in North America, Europe and Asia to manufacture the antiviral drug, which received an emergency use authorization from the FDA in May.
INVEST Pitch Perfect winner spotlight: Atentiv’s digital therapeutic for ADHD isn’t just fun and games
Judges picked Atentiv as the winner of the __ for MedCity Invest’s virtual conference. The Boston-based startup is building a game to improve attention in kids with ADHD.
Ginger, a startup that provides mental health coaching services to its members, raised $50 million in series D funding.
The annual healthcare budgeting process begins with forecasting future patient volumes, case mix, and revenue. […]
A recent Pennsylvania appellate court opinion related to the Patient Safety and Quality Improvement Act (“PSQIA”) continues a trend of judicial erosion of patient safety privilege protections afforded to health care providers by statute.
Biogen and Eisai said the FDA had accepted and given priority review to their application for aducanumab. The drug will undergo an advisory committee meeting at an undisclosed date. Biogen’s stock rose 10%, but analysts had mixed opinions.
A recently unsealed whistleblower case filed by the Department of Justice accuses Cigna of fraudulently overbilling for its Medicare Advantage plans. Allegations claim the company submitted unsupported diagnoses that resulted in “billions” in overpayments.
Ancestry, which grew from a genealogy tracking tool to offering DNA tests for a number of healthconditions, reached a deal to be acquired by Blackstone for $4.7 billion. But privacy advocates have raised concerns over the deal — namely, what would happen to users’ health… Read More »Blackstone’s $4.7B acquisition of Ancestry raises privacy questions
Oak Street Health, which operates primary care centers for Medicare patients, went public on Thursday for $328 million. Its capitation payment model has helped the company continue on where many clinics have struggled during the Covid-19 pandemic.
Blenrep, an antibody-drug conjugate, is the first drug approved for multiple myeloma that targets the antigen BCMA. Several other companies are also developing BCMA-targeting therapies for the blood cancer, including CAR-T cells and bispecific antibodies.
The new report, from the University of Pittsburgh Medical Center’s Center for Connected Medicine, surveyed 101 representatives of hospitals and healthcare systems. Nine out of 10 respondents said they were providing genomic or genetic testing or planning to.
As we look forward to the back half of the year, it’s clear that the desire for companies to commence their IPO process with organizational meetings and bake-offs continues
When reviewing a return to normal operations, there is much to consider. Here are four approaches aimed at establishing a healthy pathway back to something close to the norm.
The drug has consistently failed to show a benefit when tested in randomized, controlled clinical trials. Social science may explain why laypeople and doctors alike continue clinging to it.
The two fast-growing digital health companies struck a merger agreement on Wednesday. Teladoc will acquire Livongo in a deal that would value the startup at a whopping $18.5 billion.
MedCity Pivot Podcast: A conversation with Zeke Emanuel on policy, politics, Covid-19 and what we can learn from other nations
In this episode of MedCity Pivot podcast, we discuss Zeke Emanuel’s book where he asks the question – which country has the best healthcare in the world – and of course policy, politics, Covid-19. And his grandmother.
Teladoc will acquire digital health company Livongo for $18.5 billion. The deal would combine one of the largest telehealth companies with a platform for managing an array of chronic conditions, including diabetes and heart disease.
Health information exchanges know about the hard work of building trust by delivering value in healthcare. They have been in these trenches. They need a seat at the table with our state public health leaders as America works to safely reopen.
The company said the study of Kymriah in follicular lymphoma met its primary endpoint, though it did not disclose the trial data. It plans to submit approval applications to the FDA and EMA next year.
Under the agreement with BARDA and the Department of Defense, the drugmaker would supply 100 million doses of its vaccine, for which it published preclinical data last and is currently running a first-in-human clinical trial.
With this new cash infusion, Sight Diagnostics, which uses machine learning and AI to analyze images of blood samples, has raised a total of $124 million since its inception in 2011.
The MedCity INVEST Digital Health Virtual event, Sep 21-25 will spotlight healthcare startups in four categories. The application deadline is August 14 at 5pm ET.
Several federal agencies, including the Centers for Medicare and Medicaid Services, have indicated their interest in expanding telehealth coverage after the federal emergency period ends. But to do that, they’ll need the help of states and Congress.
Regulators with the European Commission said they would launch a full investigation of Google’s proposed acquisition of Fitbit. The deal has drawn close scrutiny from regulators who worry about the amount of data Google would be able to access.
Hanmi will retain options for the drug, efinopegdutide, in Korea under the deal, in which Merck is paying the Seoul-based company $10 million upfront and up to $860 for development, regulatory and commercialization milestones.
A webinar from HealthSparq offers analysis on a consumer sentiment study on health plans. It offers some useful insights on how the public health crisis has laid bare the trust issues consumers have and how insurers can address them to the benefit of both.
Amplified Sciences emerged as the winner of the diagnostics track for the MedCity INVEST conference’s Pitch Perfect contest with PanCystPro, the test it is developing to address the problems encountered when determining whether pancreatic cysts are cancerous.
Rural hospitals are grappling with high rates of chronic disease, lack of broadband access, and workforce shortages that are exacerbated by the low pay and professional isolation that are characteristic of rural settings. It is from within this digital divide that rural hospitals have learned… Read More »What rural hospitals can teach their urban counterparts about patient engagement
In a Q&A, Truvian Sciences CEO Jeff Hawkins and Dena Marrinucci, founder and SVP Corporate Development and Business Operations talk about their point-of care blood testing technology.
The executive order would call on the Department of Health and Human Services to develop a new pilot payment model for rural hospitals, and would set up a task force to improve broadband infrastructure in rural communities.
GoodRx, a startup that makes tools for comparing the price of prescription drugs, is looking to go public, according to a report by Reuters. The company reportedly submitted paperwork to the Securities and Exchange Commission.
Three of the companies making drugs used in the Phase II I-SPY COVID-19 study – Amgen, AbbVie and Takeda – announced the patient enrollments Monday. The study, which will enroll up to 1,500 critically ill patients, could test around 10 drugs.
Grandma doesn’t feel safe in the nursing home anymore: Innovations in remote monitoring give hope for improving home-based senior care
The Covid-19 pandemic is providing the impetus to look at the senior home health care model differently and more holistically.
The company is hoping to close its seed funding round in the next six months and aims to be in a position to seek regulatory approval for its lead asset, PLX888, in acute alcoholic hepatitis in 2023.
The FDA approved Monjuvi for second-line diffuse large B-cell lymphoma. Though the drug has the same antigen target as approved CAR-T cell therapies, it is designed for patients unable to tolerate such intensive treatments.
With more readers and greater engagement in our content than ever, we have many products that can help you reach your customer base through our content, ads, podcasts and online events. Contact us to learn more.
Financial terms of the deal were not disclosed, but it follows a $1.95 billion contract between the two companies and the U.S. government. Assuming clinical trial success and regulatory approval, they would supply the vaccines in early 2021, ahead of the rescheduled Tokyo Olympics.
Insurance startup Oscar Health plans to expand to 19 new markets next year, pending regulatory approval. The company will offer individual and family health plans in four new states, and will expand its presence in existing states.
Patient engagement platform Luma Health was designed to help patients schedule appointment with the doctor without having to wait months. With Covid-19, the startup’s vision has expanded.
The first visit can seem daunting for patients, but by offering this advice and treating the virtual visit as an extension of in-person care, it can be an easy and efficient way to conduct an appointment.
The companies will provide 100 million doses of their jointly developed vaccine. But with a Phase I/II study planned in September, it is behind in development compared with those of Moderna and Pfizer and BioNTech, which have already started late-stage clinical testing.
Strata Decision Technology, a Chicago-based company that makes decision support software, will acquire Allscripts subsidiary EPSi for $365 million.
Mount Sinai spinoff launches virtual trial network with the American Gastroenterological Association
Rx.Health, a Mount Sinai spinoff that stitches together digital healthcare tools, struck a partnership with the American Gastroenterological Association to create a virtual trial network. The company hopes to expand the toolkit to other patient registries in the future.
Delivering on the promise of precision cancer medicine and why it matters even more during a pandemic
While many of us have avoided exposure to Covid-19 by sheltering in place, patients with […]
Read about new developments and milestones in the journey of healthcare startups from Truvian Sciences, NeuroFlow and more.
We are seeking digital health startups in four categories to take part in our INVEST Digital Health Virtual event in September.